NCT00878618View on ClinicalTrials.gov

Pharmacokinetics of Extended-Release Test- and Reference Formulations of AZD0837

PHASE1CompletedINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

April 30, 2009

Study Completion Date

May 31, 2009

Conditions

Healthy

Interventions

DRUG

AZD0837

Extended-release tablets, test formulation. 2 tablets given in the morning for 6 days

DRUG

AZD0837

Extended-release tablets, reference formulation. 2 tablets given in the morning for 6 days

Trial Locations (1)

Unknown

Research Site, Uppsala

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY